Galen Biotechnologies, LLC discovers and develops potent and selective small molecule drugs by radically reengineering ribosomal translation. Its Biologically Inspired-Chemically Designed Molecules combine the strengths of encoded biological library diversity with small molecule pharmacophores for rapid discovery and design of lead candidate therapeutics.